TARS1 and breast carcinoma: In our study, we discovered that TARS1 overexpression inhibited the infiltration of anti-cancer immune cells like CD8+ T cells and NK cells while promoting the infiltration of oncogenic immune cells like Treg and Th2 in breast cancer.